R&D The future of precision psychiatry The mental health clinical trials market is expected to double to $4.27 billion in 2028, up from $2.15 billion in 2018, and
Events Partner Content International Neurology Conference Neurology-2018 welcomes you all to esteemed conference
News Vasopharm drug could limit damage caused by brain injuries German biotech moves into phase 3 after a long wait
Oncology Hernexeos and what’s next, with Vicky Brown At Reuters Pharma USA this week, Boehringer Ingelheim's Vicky Brown spoke with us about the company's recent approval for Hernexeos in NSCLC.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
